Clinical Trial

A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003

Name: A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003 — clinical trial record (NCT07623798)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate how well IBI3003 works when compared with the investigator's choice regimen (DPd or PVd)

Trial Details

NCT Number	NCT07623798
Lead Sponsor	Innovent Biologics (Suzhou) Co. Ltd.
Conditions	Relapsed or Refractory Multiple Myeloma
Enrollment	255 participants
Start Date	2026-06-05
Primary Completion	2029-05-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-03